9.58 (-%)
As of Oct 30, 2024
Source:
Atara Biotherapeutics is a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune disease.
| Country | United States |
| Headquarters | thousand oaks, california |
| Phone Number | 805-623-4244 |
| Industry | manufacturing |
| CEO | Pascal Touchon |
| Website | www.atarabio.com |